Related Experiment Video
Updated: Jul 20, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Bronchioalveolar carcinoma: five year survival]
Gustavo Lyons1, Silvia Quadrelli, Domingo Chimondegy
1Centro de Oncología Torácica, Hospital Británico, Buenos Aires, Argentina.
Medicina
|September 19, 2006
Summary
Bronchioalveolar carcinoma (BAC) shows a favorable prognosis, especially in focal forms and early stages. Non-mucinous BAC also offers better survival rates compared to the mucinous type.
Area of Science:
- Pulmonary Medicine
- Oncology
- Thoracic Surgery
Context:
- Bronchioalveolar carcinoma (BAC) presents distinct epidemiological and prognostic features compared to adenocarcinoma.
- Surgical resection is a primary treatment modality for BAC.
- Early diagnosis and classification are crucial for patient outcomes.
Purpose:
- To evaluate the epidemiology and prognosis of bronchioalveolar carcinoma (BAC) in patients undergoing surgical resection.
- To identify factors influencing survival rates in BAC patients, including clinical presentation, stage, and histology.
Summary:
- A study of 28 BAC patients revealed a 65% five-year survival rate.
- Asymptomatic presentation, focal lesions, early TNM staging (IA), and non-mucinous histology were associated with improved survival.
- Curative resections significantly improved survival outcomes compared to non-curative procedures.
Impact:
- BAC demonstrates a favorable prognosis, particularly when diagnosed early and treated with curative intent.
- Findings support the importance of histological subtype and lesion characteristics in predicting patient outcomes.
- This research aids in refining treatment strategies and prognostic assessments for bronchioalveolar carcinoma.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:26Alveoli and Alveolar Ducts
The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...